Verastem (NASDAQ:VSTM) Stock Price Expected to Rise, HC Wainwright Analyst Says
Verastem (NASDAQ:VSTM – Free Report) had its price target hoisted by HC Wainwright from $10.00 to $14.00 in a research report report published on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. VSTM has been the subject of a number of other research reports. Jefferies Financial Group initiated coverage […]
